Michael Hennessy, Jr.

Michael J. Hennessy Jr. began his career in Business Development at MJH Associates. His role at the organization grew with his success and by September 2015 he was elevated to President, and ultimately promoted to President and CEO of MJH Life Sciences. Outside of MJH Life Sciences, Mike leads GenHenn Capital and serves on the boards of various Medical Device businesses. He also serves as the President and Board member of the Mike and Patti Hennessy Foundation.

Since the beginning of his career, Mike has demonstrated his vision for creating new, innovative, and engaging ways to educate health care professionals and improve patient care worldwide. He has become a recognized leader in marketing and commercializing novel medical devices and diagnostics. After overseeing sustained organic growth, Mike further expanded and elevated MJH Life Sciences by acquiring several highly respected assets from UBM Life Sciences Group in January 2019. In 2020, Mike continued aggressively growing the organization, with the launch of Medical World News, a first-of-its kind news channel for health care professionals, and the COVID-19 Coalition, a partnership with health care thought leaders, to provide accurate information on the pandemic. In addition to organic growth and launches, Mike also continued expanding the organization through numerous acquisitions during this time.

Under Mike’s leadership, MJH Life Sciences has grown to more than 60 brands that reach millions of engaged health care stakeholders per month. In honor of his accomplishments, in early 2021 Mike received MM+M’s 40 Under 40 award and, in the summer of 2021, he was named the EY Entrepreneur Of The Year New Jersey award winner and was a national award finalist. Mike was also recently recognized as an Innovate100 Honoree for New Jersey which highlights the top innovators statewide.